1035 related articles for article (PubMed ID: 33799765)
21. Extracellular Vesicles as Drug Delivery Systems - Methods of Production and Potential Therapeutic Applications.
Surman M; Drożdż A; Stępień E; Przybyło M
Curr Pharm Des; 2019; 25(2):132-154. PubMed ID: 30848183
[TBL] [Abstract][Full Text] [Related]
22. Delivery of microRNAs by Extracellular Vesicles in Viral Infections: Could the News be Packaged?
Yoshikawa FSY; Teixeira FME; Sato MN; Oliveira LMDS
Cells; 2019 Jun; 8(6):. PubMed ID: 31216738
[TBL] [Abstract][Full Text] [Related]
23. Post-production modifications of murine mesenchymal stem cell (mMSC) derived extracellular vesicles (EVs) and impact on their cellular interaction.
Le Saux S; Aarrass H; Lai-Kee-Him J; Bron P; Armengaud J; Miotello G; Bertrand-Michel J; Dubois E; George S; Faklaris O; Devoisselle JM; Legrand P; Chopineau J; Morille M
Biomaterials; 2020 Feb; 231():119675. PubMed ID: 31838346
[TBL] [Abstract][Full Text] [Related]
24. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
25. Extracellular vesicle-based therapeutics: Extracellular vesicles as therapeutic targets and agents.
Takahashi Y; Takakura Y
Pharmacol Ther; 2023 Feb; 242():108352. PubMed ID: 36702209
[TBL] [Abstract][Full Text] [Related]
26. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
27. Virus-Free Method to Control and Enhance Extracellular Vesicle Cargo Loading and Delivery.
Bui S; Dancourt J; Lavieu G
ACS Appl Bio Mater; 2023 Mar; 6(3):1081-1091. PubMed ID: 36781171
[TBL] [Abstract][Full Text] [Related]
28. Extracellular Vesicles for Therapeutic Nucleic Acid Delivery: Loading Strategies and Challenges.
Oshchepkova A; Zenkova M; Vlassov V
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108446
[TBL] [Abstract][Full Text] [Related]
29. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
Raimondo S; Giavaresi G; Lorico A; Alessandro R
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
[TBL] [Abstract][Full Text] [Related]
30. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
Shahjin F; Chand S; Yelamanchili SV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
[TBL] [Abstract][Full Text] [Related]
32. Generation of Hybrid Extracellular Vesicles by Fusion with Functionalized Liposomes.
Piffoux M; Silva AKA; Gazeau F; Tareste D
Methods Mol Biol; 2022; 2473():385-396. PubMed ID: 35819777
[TBL] [Abstract][Full Text] [Related]
33. Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane Vesicles.
Iraci N; Leonardi T; Gessler F; Vega B; Pluchino S
Int J Mol Sci; 2016 Feb; 17(2):171. PubMed ID: 26861302
[TBL] [Abstract][Full Text] [Related]
34. A focus on critical aspects of uptake and transport of milk-derived extracellular vesicles across the Caco-2 intestinal barrier model.
Roerig J; Schiller L; Kalwa H; Hause G; Vissiennon C; Hacker MC; Wölk C; Schulz-Siegmund M
Eur J Pharm Biopharm; 2021 Sep; 166():61-74. PubMed ID: 34077790
[TBL] [Abstract][Full Text] [Related]
35. In Vivo Tracking of Extracellular Vesicles in Mice Using Fusion Protein Comprising Lactadherin and Gaussia Luciferase.
Takahashi Y; Nishikawa M; Takakura Y
Methods Mol Biol; 2017; 1660():245-254. PubMed ID: 28828662
[TBL] [Abstract][Full Text] [Related]
36. New insight into isolation, identification techniques and medical applications of exosomes.
Yang XX; Sun C; Wang L; Guo XL
J Control Release; 2019 Aug; 308():119-129. PubMed ID: 31325471
[TBL] [Abstract][Full Text] [Related]
37. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
[TBL] [Abstract][Full Text] [Related]
38. Extracellular vesicles: a rising star for therapeutics and drug delivery.
Du S; Guan Y; Xie A; Yan Z; Gao S; Li W; Rao L; Chen X; Chen T
J Nanobiotechnology; 2023 Jul; 21(1):231. PubMed ID: 37475025
[TBL] [Abstract][Full Text] [Related]
39. Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives.
Ramesh D; Bakkannavar S; Bhat VR; Sharan K
F1000Res; 2023; 12():329. PubMed ID: 37868300
[TBL] [Abstract][Full Text] [Related]
40. Translating extracellular vesicle packaging into therapeutic applications.
Ozkocak DC; Phan TK; Poon IKH
Front Immunol; 2022; 13():946422. PubMed ID: 36045692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
